InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: None

Monday, 07/25/2016 5:45:32 PM

Monday, July 25, 2016 5:45:32 PM

Post# of 16885
Under the heading of diabolical ponderings...but business is business after all. Braeburn has the US and Canada. Some patients may be denied insurance coverage in the US or Canada, but still want probuphine.

How about Titan independently offering a South of the Border alternative? According to the link, probuphine could be approved in Mexico in 60 days. Offer it for a more affordable $2,000 a treatment (instead of Braeburn's $4,950), pay $500-$600 for the rod and keep $1,500-$1,600 in profit.

You sell a thousand treatments a year in Mexico that way, and bank $16 million in profit. You would need $100 million in sales from Braeburn (20,000 treatments) to receive as much in royalty payments.


http://www.loc.gov/law/foreign-news/article/mexico-directive-allows-sale-of-pharmaceuticals-previously-approved-by-the-u-s-fda/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News